These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15851227)

  • 1. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.
    Ackerman MJ; Splawski I; Makielski JC; Tester DJ; Will ML; Timothy KW; Keating MT; Jones G; Chadha M; Burrow CR; Stephens JC; Xu C; Judson R; Curran ME
    Heart Rhythm; 2004 Nov; 1(5):600-7. PubMed ID: 15851227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
    Tester DJ; Will ML; Haglund CM; Ackerman MJ
    Heart Rhythm; 2005 May; 2(5):507-17. PubMed ID: 15840476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.
    Deschênes I; Baroudi G; Berthet M; Barde I; Chalvidan T; Denjoy I; Guicheney P; Chahine M
    Cardiovasc Res; 2000 Apr; 46(1):55-65. PubMed ID: 10727653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.
    Rook MB; Bezzina Alshinawi C; Groenewegen WA; van Gelder IC; van Ginneken AC; Jongsma HJ; Mannens MM; Wilde AA
    Cardiovasc Res; 1999 Dec; 44(3):507-17. PubMed ID: 10690282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants.
    Tan BH; Valdivia CR; Rok BA; Ye B; Ruwaldt KM; Tester DJ; Ackerman MJ; Makielski JC
    Heart Rhythm; 2005 Jul; 2(7):741-7. PubMed ID: 15992732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative results.
    Tester DJ; Cronk LB; Carr JL; Schulz V; Salisbury BA; Judson RS; Ackerman MJ
    Heart Rhythm; 2006 Jul; 3(7):815-21. PubMed ID: 16818214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
    Kapplinger JD; Tester DJ; Alders M; Benito B; Berthet M; Brugada J; Brugada P; Fressart V; Guerchicoff A; Harris-Kerr C; Kamakura S; Kyndt F; Koopmann TT; Miyamoto Y; Pfeiffer R; Pollevick GD; Probst V; Zumhagen S; Vatta M; Towbin JA; Shimizu W; Schulze-Bahr E; Antzelevitch C; Salisbury BA; Guicheney P; Wilde AA; Brugada R; Schott JJ; Ackerman MJ
    Heart Rhythm; 2010 Jan; 7(1):33-46. PubMed ID: 20129283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation.
    Tester DJ; Valdivia C; Harris-Kerr C; Alders M; Salisbury BA; Wilde AA; Makielski JC; Ackerman MJ
    Heart Rhythm; 2010 Jul; 7(7):912-9. PubMed ID: 20403459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
    Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
    Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted mutational analysis of ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects.
    Sherman J; Tester DJ; Ackerman MJ
    Heart Rhythm; 2005 Nov; 2(11):1218-23. PubMed ID: 16253912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium Channel.
    Kapplinger JD; Giudicessi JR; Ye D; Tester DJ; Callis TE; Valdivia CR; Makielski JC; Wilde AA; Ackerman MJ
    Circ Cardiovasc Genet; 2015 Aug; 8(4):582-95. PubMed ID: 25904541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome.
    Ackerman MJ; Tester DJ; Jones GS; Will ML; Burrow CR; Curran ME
    Mayo Clin Proc; 2003 Dec; 78(12):1479-87. PubMed ID: 14661677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of Brugada syndrome in Israel: two novel mutations and possible genetic heterogeneity.
    Levy-Nissenbaum E; Eldar M; Wang Q; Lahat H; Belhassen B; Ries L; Friedman E; Pras E
    Genet Test; 2001; 5(4):331-4. PubMed ID: 11960580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
    Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
    Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics, ethics and ethnicity.
    Brugada R
    Heart Rhythm; 2004 Nov; 1(5):608-9. PubMed ID: 15898185
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.
    Ackerman MJ; Siu BL; Sturner WQ; Tester DJ; Valdivia CR; Makielski JC; Towbin JA
    JAMA; 2001 Nov; 286(18):2264-9. PubMed ID: 11710892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.